Towards the design of active pharmaceutical ingredients mineralizing readily in the environment
Neele Puhlmann, Renate Mols, Oliver Olsson, J. Chris Slootweg, Klaus Kümmerer
Abstract
The optimization phase within API discovery is suitable for environmental considerations through Benign by Design. Pharmacological parameters are not necessarily in conflict with environmental biodegradability as an additional parameter.
Topics & Concepts
Active ingredientChemistryBiochemical engineeringCombinatorial chemistryBusinessBiologyEngineeringPharmacologyChemistry and Chemical EngineeringPharmaceutical and Antibiotic Environmental ImpactsComputational Drug Discovery Methods